LFSC vs. GERM
LFSC (F/m Emerald Life Sciences Innovation ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds. LFSC is actively managed, while GERM is passively managed. Over the past year, LFSC returned 58.79% vs 0.00% for GERM. LFSC charges 0.54%/yr vs 0.68%/yr for GERM.
Performance
LFSC vs. GERM - Performance Comparison
Loading charts...
Returns By Period
LFSC
- 1D
- 1.08%
- 1M
- -1.63%
- YTD
- 3.84%
- 6M
- 1.68%
- 1Y
- 58.79%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
LFSC vs. GERM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
LFSC F/m Emerald Life Sciences Innovation ETF | 3.84% | 56.54% | -6.02% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LFSC vs. GERM — Risk / Return Rank
LFSC
GERM
LFSC vs. GERM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for F/m Emerald Life Sciences Innovation ETF (LFSC) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LFSC | GERM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.38 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 3.64 | — | — |
| Martin ratioReturn relative to average drawdown | 10.14 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LFSC | GERM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.28 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.07 | — | — |
Drawdowns
LFSC vs. GERM - Drawdown Comparison
The maximum LFSC drawdown since its inception was -29.74%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for LFSC and GERM.
Loading charts...
Drawdown Indicators
| LFSC | GERM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -29.74% | 0.00% | -29.74% |
Max Drawdown (1Y)Largest decline over 1 year | -16.25% | 0.00% | -16.25% |
Current DrawdownCurrent decline from peak | -3.57% | 0.00% | -3.57% |
Average DrawdownAverage peak-to-trough decline | -7.82% | 0.00% | -7.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.82% | 0.00% | +5.82% |
Volatility
LFSC vs. GERM - Volatility Comparison
F/m Emerald Life Sciences Innovation ETF (LFSC) has a higher volatility of 7.43% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that LFSC's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LFSC | GERM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.43% | 0.00% | +7.43% |
Volatility (6M)Calculated over the trailing 6-month period | 18.52% | 0.00% | +18.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.01% | 0.00% | +26.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.90% | 0.00% | +28.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.90% | 0.00% | +28.90% |
LFSC vs. GERM - Expense Ratio Comparison
LFSC has a 0.54% expense ratio, which is lower than GERM's 0.68% expense ratio.
Dividends
LFSC vs. GERM - Dividend Comparison
Neither LFSC nor GERM has paid dividends to shareholders.
Frequently Asked Questions
LFSC has higher volatility (7.43%) compared to GERM (0.00%). In terms of maximum drawdown, LFSC dropped -29.74% vs GERM's 0.00%.
On 1-year performance, LFSC leads with 58.79% vs 0.00% for GERM. On fees, LFSC is cheaper at 0.54% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, LFSC has performed better with a 58.79% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
LFSC is cheaper with a 0.54% expense ratio, compared with 0.68% for GERM.
LFSC and GERM have nearly identical dividend yields, around 0.00%.
They also come from different issuers: F/m Investments and Amplify. Their fees differ too: 0.54% for LFSC and 0.68% for GERM.
Find the right allocation for LFSC and GERM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer